Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03718403 · ClinicalTrials.gov registry record · Phase 4
Effect of Theophylline in Pseudohypoparathyroidism
A Phase 4 study of PHP Ia and PHP IB, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT03718403 is a Phase 4 study of PHP Ia and PHP IB that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03718403, a Phase 4 study of PHP Ia and PHP IB, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The study evaluates the effect of theophylline in 100 subjects with Pseudohypoparathyroidism.
Interventions
- DRUG Theophylline
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2019-11-11 |
| Est. Completion | 2032-04-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03718403
The ClinicalTrials.gov registry entry for NCT03718403 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with PHP Ia appearing as the primary indexed condition, and to 1 intervention - of which Theophylline is the first listed.
NCT03718403 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03718403 about?
NCT03718403 is a clinical study titled "Effect of Theophylline in Pseudohypoparathyroidism". The study evaluates the effect of theophylline in 100 subjects with Pseudohypoparathyroidism.
What is the current status of trial NCT03718403?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2019-11-11. Estimated completion is 2032-04-10.
What conditions does trial NCT03718403 study?
This clinical trial studies the following conditions: PHP Ia, PHP IB, Php1C.
What interventions are being tested in trial NCT03718403?
The interventions under investigation include: Theophylline (DRUG).
Who is sponsoring clinical trial NCT03718403?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03718403 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.